HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elodie Menager-Tabourel Selected Research

Annexin A2 (Annexin II)

6/2018The combination of everolimus and zoledronic acid increase the efficacy of gemcitabine in a mouse model of pancreatic adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elodie Menager-Tabourel Research Topics

Disease

2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2024 - 01/2023
1Neoplasms (Cancer)
06/2018
1Adenocarcinoma
06/2018

Drug/Important Bio-Agent (IBA)

1Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2023
1Biomarkers (Surrogate Marker)IBA
06/2018
1Annexin A2 (Annexin II)IBA
06/2018
1Caspase 3 (Caspase-3)IBA
06/2018
1Zoledronic Acid (Zometa)FDA Link
06/2018
1GemcitabineFDA Link
06/2018
1EverolimusFDA Link
06/2018

Therapy/Procedure

1Chemoradiotherapy
01/2024
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2023
1Drug Therapy (Chemotherapy)
01/2023